Mehalick David — SEC Form 4 filings

SEC reporting owner CIK 1846623. 3 Form 4 filings on record with FilingPulse; latest filed 2026-02-13.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-01-09 to 2026-02-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Coeptis Therapeutics Holdings, Inc. (COEP)CEO and President, Director, 10% owner33 legs · 25,054 sh · $16,7473

Form 4 filings — Mehalick David

FiledFormIssuerReported transactionsSource
2026-02-134Coeptis Therapeutics Holdings, Inc. (COEP)Option exercise (M): 148,875 @ $7.05 · Grant/award (A): 51,250 @ $0EDGAR
2025-03-064Coeptis Therapeutics Holdings, Inc. (COEP)Grant/award (A): 28,875 (derivative)EDGAR
2024-01-094Coeptis Therapeutics Holdings, Inc. (COEP)Purchase (P): 5,050 @ $0.69 · Purchase (P): 6,000 @ $0.67 · Purchase (P): 14,004 @ $0.66EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1846623 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →